OSAM
SGMO

O'Shaughnessy Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-158
Closed -$1K – 2276
2021
Q3 		$1K Hold
158
– – ﹤0.01% 2633
2021
Q2 		$2K Hold
158
– – ﹤0.01% 2328
2021
Q1 		$2K Buy
158
+100
+172% +$1.35K ﹤0.01% 2092
2020
Q4 		$1K Hold
58
– – ﹤0.01% 1986
2020
Q3 		$1K Hold
58
– – ﹤0.01% 1790
2020
Q2 		$1K Buy
+58
New +$538 ﹤0.01% 1654

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

O'Shaughnessy Asset Management's SGMO Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 158 shares — an estimated $1K sold.

O'Shaughnessy Asset Management first reported a position in SGMO in Q2 2020 and held it in 6 quarters. The position peaked at $2K in Q2 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 158 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $1K.
  • O'Shaughnessy Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 6 quarters.
  • O'Shaughnessy Asset Management's SANGAMO THERAPEUTICS INC position peaked at $2K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.